Study of a new pill for depression in cancer patients
Part of Mental health clinical trials.
This trial tests an investigational pill (PDC-1421) to see if it can safely and effectively treat depression in people with cancer. If you're struggling with mood during cancer treatment, this study might offer a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 85 years old.
- You have stage I, II, or III cancer (any type).
- You are currently receiving or have received radiation or chemotherapy within the past year.
- You have moderate to severe depressive symptoms (scored 20 or higher on a standard depression scale).
- You are not currently taking any other antidepressant medications.
- You do not have a history of seizures, head trauma, or severe allergic reactions to multiple drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called NBI-1065845 added to your current antidepressant. It is for people with moderate to severe depression or persistent depressive disorder who have not improved enough with oral antidepressants alone.
This trial tests an investigational medication (NBI-1065845) added to your current antidepressant to see if it can improve depressive symptoms. It is for people with moderate to severe depression who have not fully responded to their current antidepressant.
This study tests a new medication called BMS-986511 for adults with major depressive disorder. It aims to see if the drug can help relieve depression symptoms more effectively than a placebo.
This trial tests a new medication called NBI-1065845 added to your current antidepressant for people with depression that hasn't fully responded to treatment. It aims to see if this combination can better improve your symptoms.
This study tests a new oral medication (NBI-1065845) added to your current antidepressant to see if it's safe and tolerable over a long period for people with depression that hasn't fully responded to treatment.
This trial tests a personalized approach to treating major depressive disorder using assessments and brain imaging to match you with the best therapy. It aims to improve outcomes by tailoring care to your specific needs.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.